Literature DB >> 30983047

Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.

Megan E Gumina1, Albert C Yan1.   

Abstract

Infantile hemangiomas are the most common tumors of infancy and are often managed with oral beta-blockers to address or prevent associated complications. However, treatment with propranolol can occasionally be associated with sleep disturbances, which in some cases are severe enough to warrant discontinuation or replacement with another agent. We herein report four cases in which treatment with propranolol resulted in significant sleep disturbances prompting substitution with atenolol, which in some cases resolved these issues.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Drug reaction; hemangiomas/vascular tumors

Year:  2019        PMID: 30983047     DOI: 10.1111/pde.13839

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Atenolol use for infantile hemangiomas.

Authors:  Rosalia Ballona; Felipe Velásquez'; Iris Kikushima; Jean Pierre Zevallos; Jeanette Nuñez; Consuelo Apagüeño
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

2.  Sleep disturbances as an adverse effect of propranolol use in children with infantile hemangioma.

Authors:  Ellen M S Xerfan; Monica L Andersen; Anamaria S Facina; Sergio Tufik; Jane Tomimori
Journal:  World J Pediatr       Date:  2020-02-03       Impact factor: 2.764

3.  Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma.

Authors:  Caroline T Seebauer; Matthew S Graus; Lan Huang; Alex McCann; Jill Wylie-Sears; Frank Fontaine; Tara Karnezis; David Zurakowski; Steven J Staffa; Frédéric Meunier; John B Mulliken; Joyce Bischoff; Mathias Francois
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.